Skip to main content
logo
Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
1.830
0.00 (0.00%)
At close: May 11, 2026, 4:00 PM EDT
1.805
-0.025 (-1.37%)
Pre-market: May 12, 2026, 8:59 AM EDT

Compass Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
330958200199635320
Market Cap Growth
22.85%379.19%0.34%-68.65%98.76%-
Enterprise Value
144.66757.5279.4147.24450.53178.17
Last Close Price
1.835.371.451.565.033.17
PE Ratio
--12.79-4.03-4.73-13.59-2.42
PS Ratio
--235.11---
PB Ratio
1.774.871.601.343.502.28
P/TBV Ratio
1.664.301.591.332.911.42
P/FCF Ratio
--19.48-4.45-4.90-18.50-15.05
P/OCF Ratio
--19.49-4.46-4.90-18.62-16.25
EV/Sales Ratio
--93.43---
EV/EBITDA Ratio
--5.21-0.70-0.95-11.02-2.19
EV/EBIT Ratio
--5.20-0.70-0.94-10.82-2.18
EV/FCF Ratio
--15.41-1.77-1.16-13.12-8.39
Debt / Equity Ratio
0.050.040.050.000.010.02
Debt / EBITDA Ratio
-0.13-0.07-0.06-0.04-0.07-0.05
Debt / FCF Ratio
-0.18-0.20-0.15-0.04-0.08-0.19
Net Debt / Equity Ratio
-0.99-1.01-0.96-1.01-1.01-1.00
Net Debt / EBITDA Ratio
2.471.371.063.044.491.73
Net Debt / FCF Ratio
3.474.052.683.715.356.62
Asset Turnover
-00.01000
Quick Ratio
18.9414.9614.2819.5411.5413.59
Current Ratio
19.0415.0214.9619.7312.0513.84
Return on Equity (ROE)
-35.58%-41.29%-36.07%-25.74%-24.38%-91.30%
Return on Assets (ROA)
-35.40%-80.93%-76.76%-28.25%-23.57%-79.63%
Return on Invested Capital (ROIC)
21205.10%-10190.80%-7722.50%2383.48%3421.36%-9077.83%
Return on Capital Employed (ROCE)
-37.54%-86.42%-81.32%-30.29%-25.51%-88.55%
Earnings Yield
-20.69%-7.82%-24.83%-21.15%-7.36%-41.32%
FCF Yield
-16.17%-5.13%-22.47%-20.41%-5.40%-6.64%
Buyback Yield / Dilution
-23.18%-14.78%-8.15%-20.76%-67.31%-104.28%
Total Shareholder Return
-23.18%-14.78%-8.15%-20.76%-67.31%-104.28%
Updated May 5, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q